ZimVie logo

ZimVieNASDAQ: ZIMV

Profile

Sector:

Healthcare

Country:

United States

IPO:

16 February 2022

Next earnings report:

28 February 2025

Last dividends:

N/A

Next dividends:

N/A
$387.49 M
-67%vs. 3y high
62%vs. sector
-vs. 3y high
-vs. sector
-41%vs. 3y high
40%vs. sector
-78%vs. 3y high
21%vs. sector

Price

after hours | Fri, 01 Nov 2024 20:00:22 GMT
$14.04+$0.54(+4.00%)

Dividend

No data over the past 3 years
$103.22 M$113.40 M
$103.22 M-$2.28 M

Analysts recommendations

Institutional Ownership

ZIMV Latest News

ZimVie Inc. (ZIMV) Q3 2024 Earnings Call Transcript
seekingalpha.com30 October 2024 Sentiment: POSITIVE

ZimVie Inc. (NASDAQ:ZIMV ) Q3 2024 Results Conference Call October 30, 2024 4:30 PM ET Company Participants Marissa Bych - IR, Gilmartin Group LLC Vafa Jamali - President and CEO Richard Heppenstall - CFO Conference Call Participants David Saxon - Needham & Company Matt Miksic - Barclays Marissa Bych Thank you all for joining today's call. Earlier today, ZimVie released financial results for the quarter ended September 30, 2024.

Mexico Spinal Implants Market Size, Share & Trends Analysis 2024-2030, with Focus on Market Leaders ZimVie/Highridge Medical, Medtronic and DePuy Synthes
globenewswire.com02 October 2024 Sentiment: POSITIVE

Dublin, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The "Mexico Spinal Implants Market Size, Share & Trends Analysis | 2024-2030 | MedSuite | Includes: Cervical Fixation Market, Thoracolumbar Fixation Market, and 4 more" report has been added to ResearchAndMarkets.com's offering. In 2023, Mexico's spinal implant and VCF market reached a valuation exceeding $135 million. Projected to grow at a CAGR of 6.1%, the market is expected to surpass $205 million by 2030. This comprehensive report on the Mexican spinal implant and VCF market covers various segments, including traditional cervical and thoracolumbar fixation devices, interbody devices, motion preservation devices, VCF treatment, electrical stimulation devices, and spinal surgery instrumentation. Key Market Data Insights:

ZimVie Inc. (ZIMV) Q2 2024 Earnings Call Transcript
seekingalpha.com04 August 2024 Sentiment: NEUTRAL

ZimVie Inc. (NASDAQ:ZIMV ) Q2 2024 Earnings Conference Call August 1, 2024 4:30 AM ET Company Participants Marissa Bych - IR, Gilmartin Group LLC Vafa Jamali - President and CEO Richard Heppenstall - CFO Conference Call Participants David Saxon - Needham & Company Matt Miksic - Barclays Operator Good afternoon, and welcome to ZimVie's Second Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.

ZimVie Announces FDA Clearance and U.S. Launch of GenTek® Restorative Components
globenewswire.com23 July 2024 Sentiment: POSITIVE

Addition of Premium Restorative Components Enhances ZimVie's End-to-End Implant Offerings Addition of Premium Restorative Components Enhances ZimVie's End-to-End Implant Offerings

ZimVie to Report Second Quarter Financial Results on August 1, 2024
globenewswire.com18 July 2024 Sentiment: POSITIVE

PALM BEACH GARDENS, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the second quarter 2024 after market close on Thursday, August 1, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.

ZimVie to Participate in Upcoming Investor Conferences
globenewswire.com16 May 2024 Sentiment: POSITIVE

ZimVie Inc., a global leader in the dental market, has announced its participation in two upcoming investor conferences.

ZimVie Inc. (ZIMV) Q4 2023 Earnings Call Transcript
Seeking Alpha28 February 2024 Sentiment: POSITIVE

ZimVie Inc. (ZIMV) Q4 2023 Earnings Call Transcript

ZimVie: Focusing On Higher Growth Dental Business (Rating Upgrade)
Seeking Alpha26 December 2023 Sentiment: POSITIVE

ZimVie's stock has doubled since reporting Q3 earnings, causing investors to wonder about the company's future. The company's Q3 revenues declined less than expected and the company raised full-year guidance. More importantly, ZimVie's decision to sell its spine business for $375 million jettisons an underperforming segment while solving a debt overhang.

ZimVie Inc. (ZIMV) Q3 2023 Earnings Call Transcript
Seeking Alpha01 November 2023 Sentiment: NEUTRAL

ZimVie Inc. (NASDAQ:ZIMV ) Q3 2023 Earnings Conference Call November 1, 2023 4:30 PM ET Company Participants Marissa Bych - Investor Relations, Gilmartin Group LLC Vafa Jamali - President and Chief Executive Officer Richard Heppenstall - Chief Financial Officer Conference Call Participants Lilly Wyttenbach - JPMorgan Matt Miksic - Barclays Operator Good day, and thank you for standing by. Welcome to the ZimVie Third Quarter 2023 Financial Results Conference Call.

ZimVie (ZIMV) Progresses in Dental Space With Biotivity Launch
Zacks Investment Research12 October 2023 Sentiment: POSITIVE

ZimVie's (ZIMV) Biotivity A/C Plus Membrane is a barrier membrane that contains an array of growth factors.

What type of business is ZimVie?

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide. It operates through The Dental Segment. The company offers dental implant systems; biomaterials; prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Palm Beach Gardens, Florida with additional facilities around the globe.

What sector is ZimVie in?

ZimVie is in the Healthcare sector

What industry is ZimVie in?

ZimVie is in the Medical Devices industry

What country is ZimVie from?

ZimVie is headquartered in United States

When did ZimVie go public?

ZimVie initial public offering (IPO) was on 16 February 2022

What is ZimVie website?

https://www.zimvie.com

Is ZimVie in the S&P 500?

No, ZimVie is not included in the S&P 500 index

Is ZimVie in the NASDAQ 100?

No, ZimVie is not included in the NASDAQ 100 index

Is ZimVie in the Dow Jones?

No, ZimVie is not included in the Dow Jones index

When was ZimVie the previous earnings report?

No data

When does ZimVie earnings report?

The next expected earnings date for ZimVie is 28 February 2025